25 XP   0   0   10

Intelgenx Technologs
Buy, Hold or Sell?

Let's analyse Intelgenx together

PenkeI guess you are interested in Intelgenx Technologs. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Intelgenx Technologs. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Intelgenx Technologs

I send you an email if I find something interesting about Intelgenx Technologs.

Quick analysis of Intelgenx (30 sec.)










What can you expect buying and holding a share of Intelgenx? (30 sec.)

How much money do you get?

How much money do you get?
C$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
C$-0.06
Expected worth in 1 year
C$-0.12
How sure are you?
32.5%

+ What do you gain per year?

Total Gains per Share
C$-0.06
Return On Investment
-22.9%

For what price can you sell your share?

Current Price per Share
C$0.25
Expected price per share
C$0.18 - C$0.26
How sure are you?
50%

1. Valuation of Intelgenx (5 min.)




Live pricePrice per Share (EOD)

C$0.25

Intrinsic Value Per Share

C$-0.56 - C$-0.34

Total Value Per Share

C$-0.63 - C$-0.40

2. Growth of Intelgenx (5 min.)




Is Intelgenx growing?

Current yearPrevious yearGrowGrow %
How rich?-$8m$920.7k-$6.4m-116.8%

How much money is Intelgenx making?

Current yearPrevious yearGrowGrow %
Making money-$2.8m-$2.7m-$121.7k-4.3%
Net Profit Margin-1,603.0%-1,061.4%--

How much money comes from the company's main activities?

3. Financial Health of Intelgenx (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#955 / 1031

Most Revenue
#590 / 1031

Most Profit
#366 / 1031

Most Efficient
#852 / 1031

What can you expect buying and holding a share of Intelgenx? (5 min.)

Welcome investor! Intelgenx's management wants to use your money to grow the business. In return you get a share of Intelgenx.

What can you expect buying and holding a share of Intelgenx?

First you should know what it really means to hold a share of Intelgenx. And how you can make/lose money.

Speculation

The Price per Share of Intelgenx is C$0.245. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Intelgenx.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Intelgenx, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is C$-0.06. Based on the TTM, the Book Value Change Per Share is C$-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is C$-0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is C$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Intelgenx.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 C$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per Share
Usd Eps-0.02-6.4%-0.02-6.6%-0.02-6.3%-0.01-5.7%-0.01-3.6%
Usd Book Value Change Per Share-0.01-3.0%-0.01-4.2%-0.01-2.7%0.00-1.0%0.00-0.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.01-3.0%-0.01-4.2%-0.01-2.7%0.00-1.0%0.00-0.6%
Usd Price Per Share0.14-0.17-0.22-0.32-0.48-
Price to Earnings Ratio-2.21--2.70--3.54--5.82-0.43-
Price-to-Total Gains Ratio-18.95--17.27--13.02--26.31-136.41-
Price to Book Ratio-3.04--6.92-29.34-10.51-39.15-
Price-to-Total Gains Ratio-18.95--17.27--13.02--26.31-136.41-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.1803935
Number of shares5543
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.010.00
Usd Total Gains Per Share-0.010.00
Gains per Quarter (5543 shares)-57.12-13.27
Gains per Year (5543 shares)-228.49-53.06
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-228-2380-53-63
20-457-4660-106-116
30-685-6940-159-169
40-914-9220-212-222
50-1142-11500-265-275
60-1371-13780-318-328
70-1599-16060-371-381
80-1828-18340-425-434
90-2056-20620-478-487
100-2285-22900-531-540

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%4.036.00.010.0%5.065.00.07.1%
Book Value Change Per Share0.04.00.00.0%2.010.00.016.7%4.016.00.020.0%13.027.00.032.5%23.047.00.032.9%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.070.00.0%
Total Gains per Share0.04.00.00.0%2.010.00.016.7%4.016.00.020.0%13.027.00.032.5%23.047.00.032.9%

Fundamentals of Intelgenx

About Intelgenx Technologs

IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine; INT0046/2018 and INT0055/2021 are for adult use; INT0007/2006, an oral film product for treatment of erectile dysfunction; INT0043/2015, an oral film containing montelukast for treatment of Alzheimer; INT0027/2011 to treat opioid addition; INT0010/2006 for treatment of neuropathic pain and nausea in cancer patients undergoing chemotherapy; INT0036/2013, an oral film product for schizophrenia or bipolar 1 disorder; and INT0048/2020 for animal health. It is also developing INT0039/2013, INT0053/2020, and INT0054/2020. The company has licensing, development, and supply agreement with Tilray, Inc.; and development agreement with Cynapsus Therapeutics Inc. IntelGenx Technologies Corp. was incorporated in 1999 and is headquartered in Montreal, Canada.

Fundamental data was last updated by Penke on 2024-03-11 05:32:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Intelgenx Technologs.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Intelgenx earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Intelgenx to the Biotechnology industry mean.
  • A Net Profit Margin of -867.6% means that $-8.68 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Intelgenx Technologs:

  • The MRQ is -867.6%. The company is making a huge loss. -2
  • The TTM is -1,603.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-867.6%TTM-1,603.0%+735.4%
TTM-1,603.0%YOY-1,061.4%-541.6%
TTM-1,603.0%5Y-1,480.7%-122.4%
5Y-1,480.7%10Y-839.4%-641.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-867.6%-171.8%-695.8%
TTM-1,603.0%-205.8%-1,397.2%
YOY-1,061.4%-262.1%-799.3%
5Y-1,480.7%-455.6%-1,025.1%
10Y-839.4%-589.0%-250.4%
1.1.2. Return on Assets

Shows how efficient Intelgenx is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Intelgenx to the Biotechnology industry mean.
  • -46.2% Return on Assets means that Intelgenx generated $-0.46 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Intelgenx Technologs:

  • The MRQ is -46.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -43.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-46.2%TTM-43.7%-2.5%
TTM-43.7%YOY-24.7%-19.1%
TTM-43.7%5Y-26.7%-17.0%
5Y-26.7%10Y-17.8%-8.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-46.2%-12.5%-33.7%
TTM-43.7%-12.2%-31.5%
YOY-24.7%-11.2%-13.5%
5Y-26.7%-13.4%-13.3%
10Y-17.8%-14.7%-3.1%
1.1.3. Return on Equity

Shows how efficient Intelgenx is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Intelgenx to the Biotechnology industry mean.
  • 0.0% Return on Equity means Intelgenx generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Intelgenx Technologs:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-227.0%+227.0%
TTM-5Y-140.3%+140.3%
5Y-140.3%10Y-105.4%-34.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--15.8%+15.8%
TTM--15.7%+15.7%
YOY-227.0%-13.9%-213.1%
5Y-140.3%-18.3%-122.0%
10Y-105.4%-19.2%-86.2%

1.2. Operating Efficiency of Intelgenx Technologs.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Intelgenx is operating .

  • Measures how much profit Intelgenx makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Intelgenx to the Biotechnology industry mean.
  • An Operating Margin of -745.3% means the company generated $-7.45  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Intelgenx Technologs:

  • The MRQ is -745.3%. The company is operating very inefficient. -2
  • The TTM is -1,426.7%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-745.3%TTM-1,426.7%+681.4%
TTM-1,426.7%YOY-928.4%-498.3%
TTM-1,426.7%5Y-1,287.5%-139.2%
5Y-1,287.5%10Y-734.5%-553.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-745.3%-299.1%-446.2%
TTM-1,426.7%-210.1%-1,216.6%
YOY-928.4%-279.7%-648.7%
5Y-1,287.5%-459.9%-827.6%
10Y-734.5%-596.9%-137.6%
1.2.2. Operating Ratio

Measures how efficient Intelgenx is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 9.34 means that the operating costs are $9.34 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Intelgenx Technologs:

  • The MRQ is 9.343. The company is inefficient in keeping operating costs low. -1
  • The TTM is 15.538. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ9.343TTM15.538-6.195
TTM15.538YOY10.287+5.251
TTM15.5385Y14.496+1.042
5Y14.49610Y8.657+5.839
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ9.3432.861+6.482
TTM15.5383.193+12.345
YOY10.2873.615+6.672
5Y14.4965.560+8.936
10Y8.6577.396+1.261

1.3. Liquidity of Intelgenx Technologs.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Intelgenx is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.84 means the company has $0.84 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Intelgenx Technologs:

  • The MRQ is 0.841. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.780. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.841TTM0.780+0.062
TTM0.780YOY2.372-1.592
TTM0.7805Y1.796-1.017
5Y1.79610Y2.507-0.711
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8413.986-3.145
TTM0.7804.440-3.660
YOY2.3725.552-3.180
5Y1.7966.158-4.362
10Y2.5076.492-3.985
1.3.2. Quick Ratio

Measures if Intelgenx is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Intelgenx to the Biotechnology industry mean.
  • A Quick Ratio of 0.23 means the company can pay off $0.23 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Intelgenx Technologs:

  • The MRQ is 0.228. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.748. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.228TTM0.748-0.520
TTM0.748YOY3.514-2.766
TTM0.7485Y2.252-1.504
5Y2.25210Y2.868-0.616
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2283.638-3.410
TTM0.7484.168-3.420
YOY3.5145.515-2.001
5Y2.2526.012-3.760
10Y2.8686.209-3.341

1.4. Solvency of Intelgenx Technologs.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Intelgenx assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Intelgenx to Biotechnology industry mean.
  • A Debt to Asset Ratio of 2.34 means that Intelgenx assets are financed with 234.4% credit (debt) and the remaining percentage (100% - 234.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Intelgenx Technologs:

  • The MRQ is 2.344. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.874. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ2.344TTM1.874+0.470
TTM1.874YOY0.933+0.941
TTM1.8745Y1.060+0.814
5Y1.06010Y0.762+0.298
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.3440.335+2.009
TTM1.8740.330+1.544
YOY0.9330.267+0.666
5Y1.0600.367+0.693
10Y0.7620.378+0.384
1.4.2. Debt to Equity Ratio

Measures if Intelgenx is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Intelgenx to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Intelgenx Technologs:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY9.906-9.906
TTM-5Y5.008-5.008
5Y5.00810Y3.736+1.271
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.376-0.376
TTM-0.398-0.398
YOY9.9060.334+9.572
5Y5.0080.429+4.579
10Y3.7360.476+3.260

2. Market Valuation of Intelgenx Technologs

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Intelgenx generates.

  • Above 15 is considered overpriced but always compare Intelgenx to the Biotechnology industry mean.
  • A PE ratio of -2.21 means the investor is paying $-2.21 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Intelgenx Technologs:

  • The EOD is -2.854. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.214. Based on the earnings, the company is expensive. -2
  • The TTM is -2.702. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.854MRQ-2.214-0.641
MRQ-2.214TTM-2.702+0.489
TTM-2.702YOY-3.535+0.833
TTM-2.7025Y-5.817+3.114
5Y-5.81710Y0.428-6.244
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.854-2.643-0.211
MRQ-2.214-2.418+0.204
TTM-2.702-2.742+0.040
YOY-3.535-4.123+0.588
5Y-5.817-6.257+0.440
10Y0.428-6.478+6.906
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Intelgenx Technologs:

  • The EOD is -5.446. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -4.224. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3.591. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-5.446MRQ-4.224-1.223
MRQ-4.224TTM-3.591-0.633
TTM-3.591YOY-4.235+0.645
TTM-3.5915Y-7.451+3.860
5Y-7.45110Y-14.101+6.650
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-5.446-3.244-2.202
MRQ-4.224-2.939-1.285
TTM-3.591-3.478-0.113
YOY-4.235-5.592+1.357
5Y-7.451-8.473+1.022
10Y-14.101-8.881-5.220
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Intelgenx is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -3.04 means the investor is paying $-3.04 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Intelgenx Technologs:

  • The EOD is -3.924. Based on the equity, the company is expensive. -2
  • The MRQ is -3.043. Based on the equity, the company is expensive. -2
  • The TTM is -6.919. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.924MRQ-3.043-0.881
MRQ-3.043TTM-6.919+3.876
TTM-6.919YOY29.338-36.257
TTM-6.9195Y10.511-17.430
5Y10.51110Y39.146-28.635
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.9242.124-6.048
MRQ-3.0432.041-5.084
TTM-6.9192.118-9.037
YOY29.3382.915+26.423
5Y10.5113.682+6.829
10Y39.1464.114+35.032
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Intelgenx Technologs compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.010-0.014+40%-0.009-9%-0.003-68%-0.002-81%
Book Value Per Share---0.062-0.043-32%0.007-972%0.004-1720%0.014-537%
Current Ratio--0.8410.780+8%2.372-65%1.796-53%2.507-66%
Debt To Asset Ratio--2.3441.874+25%0.933+151%1.060+121%0.762+208%
Debt To Equity Ratio----0%9.906-100%5.008-100%3.736-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.021-0.022+2%-0.021-2%-0.019-12%-0.012-44%
Free Cash Flow Per Share---0.011-0.017+50%-0.018+61%-0.016+41%-0.011+1%
Free Cash Flow To Equity Per Share--0.004-0.006+248%-0.012+403%0.000+824%0.000+1445%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---0.340--------
Intrinsic Value_10Y_min---0.564--------
Intrinsic Value_1Y_max---0.044--------
Intrinsic Value_1Y_min---0.061--------
Intrinsic Value_3Y_max---0.124--------
Intrinsic Value_3Y_min---0.181--------
Intrinsic Value_5Y_max---0.196--------
Intrinsic Value_5Y_min---0.296--------
Market Cap42791210.000+22%33185038.43041481279.608-20%52397400.000-37%75452256.922-56%114095338.961-71%
Net Profit Margin---8.676-16.030+85%-10.614+22%-14.807+71%-8.394-3%
Operating Margin---7.453-14.267+91%-9.284+25%-12.875+73%-7.345-1%
Operating Ratio--9.34315.538-40%10.287-9%14.496-36%8.657+8%
Pb Ratio-3.924-29%-3.043-6.919+127%29.338-110%10.511-129%39.146-108%
Pe Ratio-2.854-29%-2.214-2.702+22%-3.535+60%-5.817+163%0.428-617%
Price Per Share0.245+22%0.1900.238-20%0.300-37%0.432-56%0.653-71%
Price To Free Cash Flow Ratio-5.446-29%-4.224-3.591-15%-4.235+0%-7.451+76%-14.101+234%
Price To Total Gains Ratio-24.438-29%-18.952-17.266-9%-13.019-31%-26.310+39%136.407-114%
Quick Ratio--0.2280.748-70%3.514-94%2.252-90%2.868-92%
Return On Assets---0.462-0.437-5%-0.247-47%-0.267-42%-0.178-62%
Return On Equity----0%-2.2700%-1.4030%-1.0540%
Total Gains Per Share---0.010-0.014+40%-0.009-9%-0.003-68%-0.002-81%
Usd Book Value---8030087.800-5484882.775-32%920743.150-972%495677.160-1720%1836976.463-537%
Usd Book Value Change Per Share---0.007-0.010+40%-0.007-9%-0.002-68%-0.001-81%
Usd Book Value Per Share---0.046-0.031-32%0.005-972%0.003-1720%0.011-537%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.016-0.016+2%-0.015-2%-0.014-12%-0.009-44%
Usd Free Cash Flow---1446274.624-2173662.744+50%-2329942.419+61%-2033086.050+41%-1461802.573+1%
Usd Free Cash Flow Per Share---0.008-0.012+50%-0.013+61%-0.012+41%-0.008+1%
Usd Free Cash Flow To Equity Per Share--0.003-0.004+248%-0.009+403%0.000+824%0.000+1445%
Usd Market Cap31507167.923+22%24434143.79630542666.175-20%38580205.620-37%55555496.771-56%84008398.077-71%
Usd Price Per Share0.180+22%0.1400.175-20%0.221-37%0.318-56%0.481-71%
Usd Profit---2759523.989-2823286.097+2%-2701512.974-2%-2438062.949-12%-1542592.914-44%
Usd Revenue--318060.395196537.319+62%317810.347+0%301807.308+5%613141.426-48%
Usd Total Gains Per Share---0.007-0.010+40%-0.007-9%-0.002-68%-0.001-81%
 EOD+6 -2MRQTTM+19 -12YOY+12 -205Y+13 -1910Y+9 -23

3.2. Fundamental Score

Let's check the fundamental score of Intelgenx Technologs based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.854
Price to Book Ratio (EOD)Between0-1-3.924
Net Profit Margin (MRQ)Greater than0-8.676
Operating Margin (MRQ)Greater than0-7.453
Quick Ratio (MRQ)Greater than10.228
Current Ratio (MRQ)Greater than10.841
Debt to Asset Ratio (MRQ)Less than12.344
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.462
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of Intelgenx Technologs based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5063.575
Ma 20Greater thanMa 500.225
Ma 50Greater thanMa 1000.212
Ma 100Greater thanMa 2000.202
OpenGreater thanClose0.250
Total4/5 (80.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-09-302022-12-312023-03-312023-06-302023-09-30
Other Stockholders Equity  67,3211967,3403067,37017167,541-69,708-2,167
Gross Profit  -390-23-413-8-4218-41346048



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in CAD. All numbers in thousands.

Summary
Total Assets8,113
Total Liabilities19,019
Total Stockholder Equity-10,906
 As reported
Total Liabilities 19,019
Total Stockholder Equity+ -10,906
Total Assets = 8,113

Assets

Total Assets8,113
Total Current Assets3,211
Long-term Assets4,902
Total Current Assets
Cash And Cash Equivalents 1,904
Short-term Investments 173
Net Receivables 697
Inventory 81
Other Current Assets 74
Total Current Assets  (as reported)3,211
Total Current Assets  (calculated)2,929
+/- 282
Long-term Assets
Property Plant Equipment 4,657
Other Assets 245
Long-term Assets  (as reported)4,902
Long-term Assets  (calculated)4,902
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities3,816
Long-term Liabilities15,203
Total Stockholder Equity-10,906
Total Current Liabilities
Accounts payable 3,193
Other Current Liabilities 291
Total Current Liabilities  (as reported)3,816
Total Current Liabilities  (calculated)3,484
+/- 332
Long-term Liabilities
Long term Debt 14,871
Capital Lease Obligations Min Short Term Debt664
Long-term Liabilities  (as reported)15,203
Long-term Liabilities  (calculated)15,535
+/- 332
Total Stockholder Equity
Common Stock1
Other Stockholders Equity -2,167
Total Stockholder Equity (as reported)-10,906
Total Stockholder Equity (calculated)-2,166
+/- 8,740
Other
Capital Stock1
Common Stock Shares Outstanding 174,658
Net Debt 12,967
Net Invested Capital 3,965
Net Tangible Assets -10,906
Net Working Capital -605
Property Plant and Equipment Gross 10,339



Balance Sheet

Currency in CAD. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-31
> Total Assets 
0
0
0
0
0
0
0
0
0
1,155
943
651
510
1,896
1,504
1,271
3,631
2,823
2,219
1,622
1,212
1,202
3,455
2,862
2,415
1,520
2,736
1,825
1,314
3,779
3,893
4,570
5,057
4,255
3,752
4,159
3,214
3,610
3,735
6,217
6,303
6,344
5,595
6,284
5,712
5,561
7,090
8,916
7,938
8,735
13,473
12,790
11,513
10,564
15,166
13,147
10,966
12,091
11,047
20,018
18,325
15,811
13,067
11,020
12,707
11,568
10,593
11,118
10,245
20,416
20,639
17,905
18,036
14,189
11,354
9,190
10,341
7,824
8,113
8,1137,82410,3419,19011,35414,18918,03617,90520,63920,41610,24511,11810,59311,56812,70711,02013,06715,81118,32520,01811,04712,09110,96613,14715,16610,56411,51312,79013,4738,7357,9388,9167,0905,5615,7126,2845,5956,3446,3036,2173,7353,6103,2144,1593,7524,2555,0574,5703,8933,7791,3141,8252,7361,5202,4152,8623,4551,2021,2121,6222,2192,8233,6311,2711,5041,8965106519431,155000000000
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
986
780
489
353
1,630
1,318
1,036
3,413
2,613
2,032
1,464
1,068
1,056
3,288
2,703
2,258
1,378
2,578
1,666
1,156
3,629
3,759
4,296
4,599
3,759
3,247
3,656
2,670
3,006
3,040
5,550
5,569
5,541
4,737
5,255
4,089
2,901
3,283
4,172
2,765
2,105
6,643
6,352
4,966
3,798
7,882
6,044
3,796
5,209
4,062
13,063
10,602
7,983
5,339
3,220
5,701
4,444
3,501
4,305
3,553
13,838
13,989
11,437
11,656
8,190
5,811
3,788
5,102
2,664
3,211
3,2112,6645,1023,7885,8118,19011,65611,43713,98913,8383,5534,3053,5014,4445,7013,2205,3397,98310,60213,0634,0625,2093,7966,0447,8823,7984,9666,3526,6432,1052,7654,1723,2832,9014,0895,2554,7375,5415,5695,5503,0403,0062,6703,6563,2473,7594,5994,2963,7593,6291,1561,6662,5781,3782,2582,7033,2881,0561,0681,4642,0322,6133,4131,0361,3181,630353489780986000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
608
469
228
76
1,351
910
331
2,879
1,043
766
556
306
95
2,198
1,525
1,037
375
1,746
1,144
575
3,201
3,320
3,505
4,059
3,055
2,768
2,059
2,168
2,284
2,551
5,005
5,166
5,178
4,376
4,399
3,819
2,663
2,264
2,865
2,067
1,096
2,720
612
300
1,175
1,631
1,591
618
2,321
1,668
6,815
6,627
5,581
3,728
1,332
355
134
337
1,205
1,572
6,121
6,019
3,945
6,614
1,975
1,498
1,210
2,520
478
1,904
1,9044782,5201,2101,4981,9756,6143,9456,0196,1211,5721,2053371343551,3323,7285,5816,6276,8151,6682,3216181,5911,6311,1753006122,7201,0962,0672,8652,2642,6633,8194,3994,3765,1785,1665,0052,5512,2842,1682,0592,7683,0554,0593,5053,3203,2015751,1441,7463751,0371,5252,198953065567661,0432,8793319101,35176228469608000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,002
3,884
3,632
1,639
5,291
3,313
1,765
1,362
552
4,180
2,005
562
561
580
4,012
2,953
1,194
1,038
406
6,008
6,013
6,004
3,635
5,002
3,250
1,317
1,320
774
173
1737741,3201,3173,2505,0023,6356,0046,0136,0084061,0381,1942,9534,0125805615622,0054,1805521,3621,7653,3135,2911,6393,6323,8843,00200000000000000000000000000000000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
242
207
188
239
274
384
682
490
538
475
586
685
901
1,037
1,130
1,171
761
779
475
516
362
394
723
457
621
410
1,495
413
628
267
412
311
270
286
760
198
163
945
1,237
616
900
382
1,290
606
580
724
937
1,038
936
1,128
1,231
1,192
1,091
480
756
839
847
1,494
1,249
1,083
1,299
1,569
1,116
979
807
682
868
786
905
697
6979057868686828079791,1161,5691,2991,0831,2491,4948478397564801,0911,1921,2311,1289361,0389377245806061,2903829006161,2379451631987602862703114122676284131,4954106214577233943625164757797611,1711,1301,037901685586475538490682384274239188207242000000000
       Other Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
89
94
0
0
0
93
0
0
0
0
0
0
0
0
0
0
0
0
1,867
0
0
0
0
462
395
358
184
170
145
140
197
569
372
289
320
310
340
321
301
331
406
424
74
7442440633130132134031032028937256919714014517018435839546200001,867000000000000930009489000000000000000000000000000000000000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
169
164
162
158
266
186
235
218
210
188
157
144
147
167
158
157
142
158
159
158
150
134
274
458
496
505
503
544
604
695
667
734
803
858
1,029
1,623
2,660
3,807
4,744
5,173
6,630
6,830
6,438
6,547
6,766
7,284
7,103
7,170
6,882
6,985
6,955
7,723
7,828
7,728
7,800
7,006
7,124
7,092
6,813
6,692
6,578
6,650
6,468
6,380
5,999
5,543
5,402
5,239
5,160
4,902
4,9025,1605,2395,4025,5435,9996,3806,4686,6506,5786,6926,8137,0927,1247,0067,8007,7287,8287,7236,9556,9856,8827,1707,1037,2846,7666,5476,4386,8306,6305,1734,7443,8072,6601,6231,029858803734667695604544503505496458274134150158159158142157158167147144157188210218235186266158162164169000000000
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
169
164
162
158
173
186
235
218
210
188
157
144
147
167
158
157
142
158
159
158
150
134
149
333
371
380
387
438
507
608
588
664
744
805
983
1,361
2,404
3,576
4,238
4,441
5,895
6,106
5,730
5,833
6,034
6,523
6,346
6,433
6,149
6,240
6,248
7,001
7,091
7,000
7,048
6,318
6,404
6,355
6,561
6,437
6,319
6,398
6,216
6,124
5,742
5,301
5,157
4,994
4,910
4,657
4,6574,9104,9945,1575,3015,7426,1246,2166,3986,3196,4376,5616,3556,4046,3187,0487,0007,0917,0016,2486,2406,1496,4336,3466,5236,0345,8335,7306,1065,8954,4414,2383,5762,4041,361983805744664588608507438387380371333149134150158159158142157158167147144157188210218235186173158162164169000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
125
125
125
125
116
106
97
87
79
70
59
53
46
25
16
6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000061625465359707987971061161251251251250000000000000000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
720
737
252
255
259
252
252
256
257
242
245
245
250
245
24525024524524225725625225225925525273772000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
4
7
9
11
15
17
20
22
23
263
357
323
296
781
886
1,059
1,570
1,415
1,584
1,450
1,609
1,684
797
705
964
1,024
315
349
278
382
376
666
1,396
1,283
1,252
1,981
1,345
1,105
1,007
1,209
872
778
702
1,711
1,496
1,470
1,784
3,352
3,018
4,592
8,623
7,845
6,529
5,398
10,376
9,318
9,033
10,416
10,599
10,031
10,523
10,393
10,428
10,727
9,993
10,134
10,680
12,071
13,286
13,576
15,426
14,034
17,422
12,544
12,482
12,613
16,654
16,979
19,019
19,01916,97916,65412,61312,48212,54417,42214,03415,42613,57613,28612,07110,68010,1349,99310,72710,42810,39310,52310,03110,59910,4169,0339,31810,3765,3986,5297,8458,6234,5923,0183,3521,7841,4701,4961,7117027788721,2091,0071,1051,3451,9811,2521,2831,3966663763822783493151,0249647057971,6841,6091,4501,5841,4151,5701,059886781296323357263232220171511974
   > Total Current Liabilities 
4
7
9
11
15
17
20
22
23
85
162
154
132
250
165
261
742
623
1,490
1,368
1,530
1,598
703
705
964
1,024
315
349
278
382
376
666
441
514
560
1,366
806
644
621
901
641
624
625
1,711
1,140
1,130
1,490
1,779
1,061
1,734
6,066
5,235
4,073
3,060
2,976
2,077
2,097
2,736
2,873
2,722
2,597
2,395
2,577
8,447
7,856
4,106
4,667
4,368
5,817
4,991
8,096
7,020
7,105
2,260
2,240
2,374
11,289
11,597
3,816
3,81611,59711,2892,3742,2402,2607,1057,0208,0964,9915,8174,3684,6674,1067,8568,4472,5772,3952,5972,7222,8732,7362,0972,0772,9763,0604,0735,2356,0661,7341,0611,7791,4901,1301,1401,7116256246419016216448061,3665605144416663763822783493151,0249647057031,5981,5301,3681,49062374226116525013215416285232220171511974
       Short-term Debt 
0
0
0
0
0
0
0
0
0
13
13
24
24
0
0
0
0
0
598
715
860
1,040
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
39
60
74
184
326
577
589
704
710
728
776
772
752
736
749
692
856
875
848
6,506
5,978
2,080
2,260
2,213
3,723
2,675
5,600
4,532
4,616
282
266
272
8,775
8,798
0
08,7988,7752722662824,6164,5325,6002,6753,7232,2132,2602,0805,9786,50684887585669274973675277277672871070458957732618474603900000000000000000000001,0408607155980000024241313000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,126
2,047
3,553
2,500
5,317
4,247
4,327
0
0
0
8,500
8,500
0
08,5008,5000004,3274,2475,3172,5003,5532,0472,126000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
3
5
2
3
0
0
0
0
73
149
130
107
250
165
261
742
623
731
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,595
0
0
826
897
613
452
1,222
1,305
1,345
2,000
2,124
2,030
1,741
0
0
0
0
0
0
1,989
1,949
2,182
2,304
2,299
2,351
1,978
1,974
2,102
0
0
3,193
3,193002,1021,9741,9782,3512,2992,3042,1821,9491,9890000001,7412,0302,1242,0001,3451,3051,222452613897826001,595000000000000000000000000000073162374226116525010713014973000032530
       Other Current Liabilities 
0
4
4
9
13
0
19
22
23
0
0
0
0
0
0
0
0
0
161
653
670
558
0
0
0
0
0
0
0
0
0
0
396
283
252
1,058
498
336
313
593
283
266
267
466
245
604
1,340
0
735
1,157
0
0
0
0
0
0
0
0
0
0
0
1,520
1,729
1,941
1,878
2,026
2,212
1,989
1,949
2,182
2,304
2,299
2,351
1,978
1,974
2,102
2,514
2,799
291
2912,7992,5142,1021,9741,9782,3512,2992,3042,1821,9491,9892,2122,0261,8781,9411,7291,520000000000001,15773501,3406042454662672662835933133364981,05825228339600000000005586706531610000000002322190139440
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
178
195
169
164
531
721
798
828
792
94
82
80
86
94
0
0
0
0
0
0
0
0
0
955
769
692
615
539
461
386
308
231
154
77
0
356
340
294
1,573
1,957
2,858
2,557
2,610
2,456
2,338
7,400
7,241
6,936
7,680
7,726
7,309
7,926
7,998
7,851
2,280
2,137
6,028
6,013
7,703
7,469
8,585
7,330
7,014
10,317
10,284
10,242
10,239
5,365
5,382
15,203
15,2035,3825,36510,23910,24210,28410,3177,0147,3308,5857,4697,7036,0136,0282,1372,2807,8517,9987,9267,3097,7267,6806,9367,2417,4002,3382,4562,6102,5572,8581,9571,5732943403560771542313083864615396156927699550000000009486808294792828798721531164169195178000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,538
7,221
7,006
8,140
6,557
6,293
9,713
9,744
9,777
9,814
4,990
5,049
0
05,0494,9909,8149,7779,7449,7136,2936,5578,1407,0067,2215,538000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
82
79
0
0
0
0
0
0
0
000000079820000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
-4
-7
-9
-11
-15
-17
-20
-22
-23
892
586
328
214
1,115
618
212
2,061
1,408
636
172
-398
-482
2,658
2,157
1,451
496
2,421
1,476
1,036
3,397
3,517
3,904
3,661
2,972
2,500
2,178
1,869
2,505
2,728
5,008
5,431
5,566
4,893
4,573
4,216
4,091
5,306
5,564
4,920
4,143
4,850
4,945
4,984
5,166
4,790
3,829
1,933
1,675
448
9,987
7,802
5,418
2,639
293
2,714
1,434
-87
-953
-3,041
6,840
5,213
3,871
614
1,645
-1,128
-3,423
-6,313
-9,155
-10,906
-10,906-9,155-6,313-3,423-1,1281,6456143,8715,2136,840-3,041-953-871,4342,7142932,6395,4187,8029,9874481,6751,9333,8294,7905,1664,9844,9454,8504,1434,9205,5645,3064,0914,2164,5734,8935,5665,4315,0082,7282,5051,8692,1782,5002,9723,6613,9043,5173,3971,0361,4762,4214961,4512,1572,658-482-3981726361,4082,0612126181,115214328586892-23-22-20-17-15-11-9-7-4
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
926
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
111111111111111111111111111111111111111111100000000000000000000009260000000000000
   Retained Earnings -77,077-74,318-71,454-68,530-65,786-63,110-60,526-57,863-55,005-53,003-50,812-48,551-47,274-45,614-43,964-41,507-38,846-36,039-33,435-30,896-28,397-25,453-23,052-20,788-19,697-18,915-18,249-17,737-18,113-18,143-17,303-16,557-16,824-18,176-17,902-17,848-17,592-17,158-16,544-16,102-15,458-14,859-14,949-14,463-14,125-13,427-12,795-12,213-11,480-10,941-10,361-9,761-8,743-8,380-7,437-6,665-6,090-5,434-5,318-4,725-4,373-3,534-2,382-1,919-1,559-1,025-958-818-414-164-25-23-20-18-16-12-10-7-4
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
48,003
48,051
48,453
48,662
61,043
61,589
63,104
62,842
67,119
67,321
67,340
67,370
67,541
0
067,54167,37067,34067,32167,11962,84263,10461,58961,04348,66248,45348,05148,00300000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
1
1
1,051
995
1,166
1,190
1,201
2,098
2,072
4,437
4,926
5,046
5,081
5,114
5,162
8,772
8,810
8,820
8,853
11,073
11,087
11,207
14,090
14,968
15,918
16,166
16,181
16,298
16,342
16,554
17,171
17,919
20,934
22,030
22,618
22,635
22,654
22,674
22,768
22,821
22,846
22,909
22,938
23,583
23,700
24,207
24,939
25,149
25,253
25,698
27,872
29,571
42,048
42,155
42,250
42,330
42,635
47,950
48,003
48,051
48,453
48,662
61,043
61,589
63,104
62,842
67,119
67,321
67,340
67,370
67,541
-2,167
-2,16767,54167,37067,34067,32167,11962,84263,10461,58961,04348,66248,45348,05148,00347,95042,63542,33042,25042,15542,04829,57127,87225,69825,25325,14924,93924,20723,70023,58322,93822,90922,84622,82122,76822,67422,65422,63522,61822,03020,93417,91917,17116,55416,34216,29816,18116,16615,91814,96814,09011,20711,08711,0738,8538,8208,8108,7725,1625,1145,0815,0464,9264,4372,0722,0981,2011,1901,1669951,051110000000



Balance Sheet

Currency in CAD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue786
Cost of Revenue-1,669
Gross Profit--883
 
Operating Income (+$)
Gross Profit-
Operating Expense-10,834
Operating Income--10,834
 
Operating Expense (+$)
Research Development3,245
Selling General Administrative5,143
Selling And Marketing Expenses-
Operating Expense10,8348,388
 
Net Interest Income (+$)
Interest Income30
Interest Expense-1,273
Other Finance Cost-0
Net Interest Income-1,243
 
Pretax Income (+$)
Operating Income-
Net Interest Income-1,243
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-0
EBIT - interestExpense = -1,273
-11,291
-10,018
Interest Expense1,273
Earnings Before Interest and Taxes (EBIT)-1,273
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-
Tax Provision--
Net Income From Continuing Ops-11,2910
Net Income-11,291
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-1,243
 

Technical Analysis of Intelgenx
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Intelgenx. The general trend of Intelgenx is BULLISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Intelgenx's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (71.4%) Bearish trend (-71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Intelgenx Technologs.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 0.25 < 0.25 < 0.26.

The bearish price targets are: 0.21 > 0.2 > 0.18.

Tweet this
Intelgenx Technologs Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Intelgenx Technologs. The current mas is .

The long score for the Moving Averages is 12/14.
The longshort score for the Moving Averages is 10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Intelgenx Technologs Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Intelgenx Technologs. The current macd is 0.00754898.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Intelgenx price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Intelgenx. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Intelgenx price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Intelgenx Technologs Daily Moving Average Convergence/Divergence (MACD) ChartIntelgenx Technologs Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Intelgenx Technologs. The current adx is 16.46.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Intelgenx shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Intelgenx Technologs Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Intelgenx Technologs. The current sar is 0.19991012.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Intelgenx Technologs Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Intelgenx Technologs. The current rsi is 63.57. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 3/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
Intelgenx Technologs Daily Relative Strength Index (RSI) ChartIntelgenx Technologs Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Intelgenx Technologs. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 5/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Intelgenx price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Intelgenx Technologs Daily Stochastic Oscillator ChartIntelgenx Technologs Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Intelgenx Technologs. The current cci is 162.16.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Intelgenx Technologs Daily Commodity Channel Index (CCI) ChartIntelgenx Technologs Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Intelgenx Technologs. The current cmo is 36.91.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Intelgenx Technologs Daily Chande Momentum Oscillator (CMO) ChartIntelgenx Technologs Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Intelgenx Technologs. The current willr is -10.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Intelgenx Technologs Daily Williams %R ChartIntelgenx Technologs Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Intelgenx Technologs.

Intelgenx Technologs Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Intelgenx Technologs. The current atr is 0.01180935.

Intelgenx Technologs Daily Average True Range (ATR) ChartIntelgenx Technologs Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Intelgenx Technologs. The current obv is 160,500.

Intelgenx Technologs Daily On-Balance Volume (OBV) ChartIntelgenx Technologs Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Intelgenx Technologs. The current mfi is 35.98.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Intelgenx Technologs Daily Money Flow Index (MFI) ChartIntelgenx Technologs Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Intelgenx Technologs.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-06STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-16STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-17MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-21STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-22STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-11MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-19BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-20ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-21ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-10WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-15RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-25WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-12MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside

6.3. Candlestick Patterns

Intelgenx Technologs Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Intelgenx Technologs based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5063.575
Ma 20Greater thanMa 500.225
Ma 50Greater thanMa 1000.212
Ma 100Greater thanMa 2000.202
OpenGreater thanClose0.250
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Intelgenx with someone you think should read this too:
  • Are you bullish or bearish on Intelgenx? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Intelgenx? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Intelgenx Technologs

I send you an email if I find something interesting about Intelgenx Technologs.


Comments

How you think about this?

Leave a comment

Stay informed about Intelgenx Technologs.

Receive notifications about Intelgenx Technologs in your mailbox!